Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bicarbonate and butylscopolamine bromide for facilitating spontaneous delivery during induction of labor
2021-000392-37Phase 3Active
- Sponsor
- Oslo University Hospital
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium bicarbonate and hyoscine butylbromide in labor dystocia and induced labor (4 arms), sponsored by Oslo University Hospital. Primary endpoint: Spontaneous vaginal delivery. Started Mar 2021; status: active.
02
Drugs
sodium bicarbonatehyoscine butylbromide
03
Conditions
labor dystociainduced labor
Beyond the preview
Go deeper on 2021-000392-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000392-37.